GCG and Hyperglycemia: GLP-1, upon its binding to its receptors on pancreatic β-cells, stimulates insulin release in a glucose-dependent manner, while concurrently inhibites glucagon release from pancreatic α-cells during hyperglycemia, thereby contributing to lower fasting and postprandial blood glucose levels [25].